Berlin, Germany

Michael Willenbrock


 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2021

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Michael Willenbrock

Introduction

Michael Willenbrock, a prominent inventor based in Berlin, Germany, holds a significant patent in the field of cancer treatment. His innovative research focuses on selective inhibitors of genotoxic stress-induced signaling pathways, contributing to advancements in medical therapeutics.

Latest Patents

Willenbrock's notable patent, titled "Selective inhibitors of genotoxic stress-induced IKK/NF-κB pathways," introduces a method for treating diseases associated with genotoxic stress. This method encompasses the administration of a compound to subjects suffering from cancer that exhibits genotoxic stress-induced activation of the IKK/NF-κB signaling pathway. This invention emphasizes the potential for targeted therapies in oncology, showcasing how research can lead to new treatment possibilities.

Career Highlights

Throughout his career, Michael Willenbrock has made significant contributions to molecular medicine. He has been associated with esteemed institutions, including the Max-Delbrück-Centrum für Molekulare Medizin in der Helmholtz-Gemeinschaft and the Forschungsverbund Berlin E.V. His work in these organizations has played a crucial role in furthering research related to cancer and genetic stress responses.

Collaborations

Willenbrock has collaborated with notable colleagues, including Claus Scheidereit and Peter Lindemann. These partnerships have enhanced his research capabilities and expanded the impact of his findings in the scientific community, further demonstrating the importance of collaboration in research and innovation.

Conclusion

In conclusion, Michael Willenbrock is a distinguished inventor whose contributions to cancer treatment through innovative patenting highlight the synergy between research, innovation, and clinical application. His work exemplifies the ongoing quest for new methods to combat diseases and improve patient outcomes, marking him as a significant figure in the field of molecular medicine.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…